Strata Critical Medical, Inc. (SRTA)
| Market Cap | 458.59M |
| Revenue (ttm) | 228.58M |
| Net Income (ttm) | 46.99M |
| Shares Out | 86.53M |
| EPS (ttm) | 0.56 |
| PE Ratio | 9.76 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,079,916 |
| Open | 5.30 |
| Previous Close | 5.36 |
| Day's Range | 5.18 - 5.38 |
| 52-Week Range | 3.68 - 6.50 |
| Beta | 2.20 |
| Analysts | Strong Buy |
| Price Target | 9.25 (+74.53%) |
| Earnings Date | Aug 15, 2026 |
About SRTA
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perf... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for SRTA stock is "Strong Buy." The 12-month stock price target is $9.25, which is an increase of 74.53% from the latest price.
News
Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
Network of experienced transplant surgeons in key markets will immediately become available to all Strata customers Adds significant scale to Transplant Clinical, Strata's fastest growing business lin...
Strata Critical Medical Transcript: 16th Annual East Coast IDEAS Conference
The company has transformed into a leading, integrated transplant logistics and clinical services provider, achieving rapid organic growth and leveraging regulatory and technological trends to outpace industry expansion. Strong financials and a flexible, asset-light model support ongoing M&A and organic growth initiatives.
Strata Acquires Louisville Perfusion Services
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that it has completed the acquisition of Louisville Perfusion Servi...
Strata Critical Medical Transcript: AGM 2026
The meeting featured board leadership transitions, approval of all shareholder proposals—including director elections, auditor ratification, and executive compensation—and reaffirmed corporate governance practices. Stockholders were encouraged to participate in Q&A and future compensation decisions will reflect their input.
AIAI Holdings Corporation Announces Appointment of Board of Directors
Directors bring a strong combination of technology, healthcare, national security, leadership experience, and financial and capital markets backgrounds AIAI Expected to Begin Trading on May 14, 2026 ...
Strata Critical Medical Slides: Investor presentation
Strata Critical Medical has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
Strata Critical Medical Announces Expiration of Warrants
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), announced that its warrants, both the Public Warrants (Nasdaq: SRTAW) and the Privat...
Strata Critical Medical Earnings Call Transcript: Q1 2026
Q1 2026 saw 87% revenue growth, strong clinical and logistics performance, and positive cash flow. Guidance for 2026 is reiterated, with continued M&A activity and industry trends supporting growth. Cash and liquidity remain robust.
Strata Critical Medical Earnings release: Q1 2026
Strata Critical Medical released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Strata Critical Medical Slides: Q1 2026
Strata Critical Medical has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Strata Critical Medical Quarterly report: Q1 2026
Strata Critical Medical has published its Q1 2026 quarterly earnings report on May 6, 2026.
Strata Critical Medical Announces First Quarter 2026 Results
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced financial results for the first quarter ended March 31, 2026. Financ...
Strata Acquires Ohio Valley Perfusion Associates
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced that it has completed the acquisition of Ohio Valley Perfusion Ass...
Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the first quarter ended March 31, 2026 on Wednesday ...
Strata Critical Medical Transcript: 25th Annual Needham Virtual Healthcare Conference
The company leverages an asset-light, end-to-end logistics and clinical platform to drive growth in the fragmented organ transplant market, benefiting from regulatory changes and advances in perfusion technology. Its agnostic approach to devices, national footprint, and targeted acquisitions position it for continued above-market expansion.
Strata Critical Medical Proxy statement: Proxy filing
Strata Critical Medical filed a proxy statement on April 14, 2026, providing details for shareholder voting and corporate governance matters.
Strata Critical Medical Proxy statement: Proxy filing
Strata Critical Medical filed a proxy statement on April 14, 2026, providing details for shareholder voting and corporate governance matters.
Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 25th Annual Needham Virtual He...
Strata Critical Medical Earnings Call Transcript: Q4 2025
Q4 2025 saw 35% organic growth, record revenue, and margin expansion, driven by logistics and clinical integration. 2026 guidance was raised on strong volumes and new customer wins, with continued M&A and asset-light strategy supporting growth.
Strata Critical Medical Annual report: Q4 2025
Strata Critical Medical has published its Q4 2025 annual report on March 3, 2026.
Strata Critical Medical Earnings release: Q4 2025
Strata Critical Medical released its Q4 2025 earnings on March 3, 2026, summarizing the period's financial results.
Strata Critical Medical Slides: Q4 2025
Strata Critical Medical has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 3, 2026.
Strata Critical Medical Announces Fourth Quarter 2025 Results
Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025 Logistics revenue and gross profit grew 35.3% and 39.5% year-over-year, respectively, in Q4 2025, which represents Strata's organic g...
Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the fourth quarter ended December 31, 2025 on Tuesday,...
Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution
$30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditions Owned aircraft excluded from collateral package and re...